Symptoms include: Diarrhea (typically watery but not bloody) Low-grade fever Nausea Occasional muscle aches or headache Stomach cramps and pain Vomiting The vomiting and diarrhea are the largest concerns, as patients can quickly become dehydrated
There is no membership fee, no buried add-on, and no starter rate that resets after the first month
This trend raises concerns about physicians restricting GLP-1 prescriptions to the most severe cases of obesity, despite FDA approval for use in individuals with BMIs of 30 or higher, or 27 with a comorbidity
What the GLP-1 Conversation Is Getting Wrong Here is what gets left out: eating disorders are common in the very population most likely to be prescribed GLP-1 medications
Many insurance plans, including employer-sponsored ones, provide coverage for GLP-1 medications like Zepbound to match specific health criteria
Patients should be aware that rapid improvement in glucose control has been associated with temporary worsening of diabetic retinopathy, particularly in those with pre-existing retinopathy